Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

被引：0

作者：

Antoine Roquilly

Bruno Francois

Olivier Huet

Yoann Launey

Sigismond Lasocki

Emmanuel Weiss

Melanie Petrier

Yannick Hourmant

Marwan Bouras

Karim Lakhal

Cecilia Le Bel

Delphine Flattres Duchaussoy

Laia Fernández-Barat

Adrian Ceccato

Laurent Flet

Alexandra Jobert

Jeremie Poschmann

Veronique Sebille

Fanny Feuillet

Despoina Koulenti

Antoni Torres

机构：

[1] Nantes Université,ICU Department and Inserm CIC 1435 & UMR 1092

[2] CHU Nantes,Département d’anesthésie réanimation et medecine peri

[3] INSERM,operatoire, CHRU de Brest

[4] Anesthesie Réanimation,Department of Anaesthesia, Critical Care and Perioperative Medicine

[5] CIC 1413,Department of Anesthesiology and Critical Care Medicine

[6] Nantes Université,Department of Anesthesiology and Critical Care

[7] CHU Nantes,2nd Critical Care Department

[8] INSERM,Faculty of Medicine, UQ Centre for Clinical Research

[9] Center for Research in Transplantation and Translational Immunology,undefined

[10] UMR 1064,undefined

[11] University Hospital of Limoges,undefined

[12] Université de Bretagne Occidentale,undefined

[13] Univ Rennes,undefined

[14] CHU Rennes,undefined

[15] University Hospital of Angers,undefined

[16] Université Paris Cité,undefined

[17] INSERM UMR_S1149,undefined

[18] and AP-HP Nord,undefined

[19] Hôpital Beaujon,undefined

[20] CELLEX research laboratories,undefined

[21] CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias,undefined

[22] 06/06/0028),undefined

[23] Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),undefined

[24] Servei de Pneumologia,undefined

[25] Hospital Clinic,undefined

[26] Barcelona,undefined

[27] Universitat de Barcelona,undefined

[28] CIBERES,undefined

[29] Icrea,undefined

[30] IDIBAPS,undefined

[31] Nantes Université,undefined

[32] CHU Nantes,undefined

[33] Pharmacie,undefined

[34] Nantes Université,undefined

[35] CHU Nantes,undefined

[36] DRI,undefined

[37] Département promotion,undefined

[38] cellule vigilances recherche,undefined

[39] Nantes Université,undefined

[40] CHU Nantes,undefined

[41] DRI,undefined

[42] Plateforme de Méthodologie et de Biostatistique,undefined

[43] Nantes Université,undefined

[44] Université de Tours,undefined

[45] CHU Nantes,undefined

[46] CHU Tours,undefined

[47] INSERM,undefined

[48] SPHERE U1246,undefined

[49] Attikon University Hospital,undefined

[50] The University of Queensland,undefined

来源：

Intensive Care Medicine | 2023年 / 49卷

关键词：

Intensive care; Hospital-acquired pneumonia; Interferon-gamma; Immunotherapy; Immunosuppression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：530 / 544

页数：14

共 24 条

[21] Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
Kiguchi, Toru
Yamaguchi, Masaki
Takezako, Naoki
Miyawaki, Shuichi
Masui, Koichi
Ihara, Yuichiro
Hirota, Masao
Shimofurutani, Naoko
Naoe, Tomoki
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1419 - 1430
[22] Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
Toru Kiguchi
Masaki Yamaguchi
Naoki Takezako
Shuichi Miyawaki
Koichi Masui
Yuichiro Ihara
Masao Hirota
Naoko Shimofurutani
Tomoki Naoe
Cancer Immunology, Immunotherapy, 2022, 71 : 1419 - 1430
[23] Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes
Maffi, Paola
Lundgren, Torbjorn
Tufveson, Gunnar
Rafael, Ehab
Shaw, James A. M.
Liew, Aaron
Saudek, Frantisek
Witkowski, Piotr
Golab, Karolina
Bertuzzi, Federico
Gustafsson, Bengt
Daffonchio, Luisa
Ruffini, Pier Adelchi
Piemonti, Lorenzo
Nano, Rita
Mercalli, Alessia
Lampasona, Vito
Magistretti, Paola
Sordi, Valeria
Antonio, Secchi
Antonioli, Barbara
Galuzzi, Marta
Tosca, Marta Cecilia
De Carlis, Luciano
Colussi, Giacomo
Korsgren, Olle
Pollard, Helena
DIABETES CARE, 2020, 43 (04) : 710 - 718
[24] Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised , placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
Cullen, Nicholas C.
Novak, Petr
Tosun, Duygu
Kovacech, Branislav
Hanes, Jozef
Kontsekova, Eva
Fresser, Michal
Ropele, Stefan
Feldman, Howard H.
Schmidt, Reinhold
Winblad, Bengt
Zilka, Norbert
EBIOMEDICINE, 2024, 99

← 1 2 3 →